Tonix Pharmaceuticals Holding (TNXP) Intangibles (2015 - 2026)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Intangibles came in at $120000.0 in Q1 2026, little changed year-on-year from $120000.0 in Q1 2025, and little changed quarter-over-quarter from $120000.0 in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Intangibles (2015 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Intangibles history runs 12 years deep, the most recent figure standing at $120000.0 for Q1 2026.
- On a quarterly basis, Intangibles changed 0.0% year-over-year to $120000.0 in Q1 2026; TTM through Mar 2026 was $120000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $120000.0, changed 0.0% from the prior year.
- Intangibles was little changed at $120000.0 in Q1 2026 per TNXP's latest filing, from $120000.0 in the prior quarter.
- Across five years, Intangibles topped out at $10.1 million in Q2 2023 and bottomed at $120000.0 in Q4 2022.
- The 5-year median for Intangibles is $120000.0 (2022), against an average of $3.1 million.
- Across the five-year window, Intangibles surged 7919.17% in 2023 and plunged 98.81% in 2024, its largest moves.
- Year by year, Intangibles stood at $120000.0 in 2022, then jumped by 7919.17% to $9.6 million in 2023, then plunged by 98.75% to $120000.0 in 2024, then changed by 0.0% to $120000.0 in 2025, then changed by 0.0% to $120000.0 in 2026.
- Per Business Quant, the three latest TNXP Intangibles figures stand at $120000.0 (Q1 2026), $120000.0 (Q4 2025), and $120000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | 11,640.44 |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn | 61.68 Mn |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | - |
| 10 | Tonix Pharmaceuticals Holding | 141.32 Mn | 141.32 Mn | 5.30 Mn | 120,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120,000.00 |
| Dec 31, 2025 | 120,000.00 |
| Sep 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Mar 31, 2025 | 120,000.00 |
| Dec 31, 2024 | 120,000.00 |
| Sep 30, 2024 | 120,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 9.39 Mn |
| Dec 31, 2023 | 9.62 Mn |
| Sep 30, 2023 | 9.98 Mn |
| Jun 30, 2023 | 10.10 Mn |
| Dec 31, 2022 | 120,000.00 |
| Dec 31, 2021 | 120,000.00 |
| Sep 30, 2021 | 120,000.00 |
| Jun 30, 2021 | 120,000.00 |
| Mar 31, 2021 | 120,000.00 |
| Dec 31, 2020 | 120,000.00 |
| Sep 30, 2020 | 120,000.00 |
| Jun 30, 2020 | 120,000.00 |